ADAC sees higher revenue and income
Nuclear medicine and information systems vendor ADAC Laboratoriesreported sharply higher sales and net income for its second quarter(end-March). The Milpitas, CA, company posted revenues of $58.4million, a company record, compared with revenues of $44.7
Nuclear medicine and information systems vendor ADAC Laboratoriesreported sharply higher sales and net income for its second quarter(end-March). The Milpitas, CA, company posted revenues of $58.4million, a company record, compared with revenues of $44.7 millionin the second quarter of 1995. Net income rose to $3.9 million,compared with $2.8 million in the corresponding period a yearago.
Bookings also increased, jumping 36% to $61 million and addingto the company's backlog. Nuclear medicine product bookings were$40 million for the quarter, a strong increase over the $31 millionin the same period last year but lower than the $48 million inthe first quarter of 1996. ADAC chairman and CEO David Lowe saidthat the drop was most likely due to a seasonal softening of theU.S. nuclear medicine market, as well as a reduction in servicecontract renewals commonly experienced in the second quarter.
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.
